Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Karim Dip"'
Autor:
Svetlana V Doubova, Adriana Monroy, Saúl Eduardo Contreras Sánchez, Rocío Grajales Álvarez, Wendy Jazmín Martínez Pineda, Jose Gustavo Nuñez Cerrillo, Rita Zalapa Velázquez, Ingrid Patricia Martinez Vega, Ricardo Villalobos Valencia, Abdel Karim Dip Borunda, Lorena Lio Mondragón, Alma Diana Huerta López, Valeria Mendoza Ortiz, Víctor Javier Vázquez Zamora, Álvaro José Montiel Jarquín, Arturo García Galicia, Enrique Isay Talamantes Gómez, Roberto Sánchez Reyes, Jaqueline Aguirre Gómez, María Eugenia Ayala Anzures, Marta Zapata Tarrés, Hannah H. Leslie
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Objectives This study aimed to explore the acceptability, feasibility, usability, and preliminary effect of an electronic patient-reported outcome (ePRO) intervention for patients with breast cancer in Mexico.Design We conducted a multimethod non-ran
Externí odkaz:
https://doaj.org/article/1ba1ef4b07a543d085e7327608fb27b3
Autor:
Rocio Grajales-Alvarez, Alicia Gutiérrez-Mata, Christian Pichardo-Piña, Marcos Gutiérrez-De la Barrera, Karim Dip-Borunda
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEThe Instituto Mexicano del Seguro Social is a tripartite contribution providing care to more than 74 million beneficiaries, representing more than 50% of the country's general population. This study aims to describe the survival outcomes and c
Externí odkaz:
https://doaj.org/article/e79ec1454ea74e88b0051dd9ac17b315
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Germán Calderillo-Ruiz, Laura Torrecillas-Torres, Alejandro Silva, Erika Ruiz-García, Alberto Pimentel-Rentería, Carlos Hernández-Hernández, Tirzo Suárez-Sahui, Isabel Enríquez-Aceves, Saúl Campos-Gómez, Marytere Herrera, Karim Dip, Consuelo Díaz-Romero
Publikováno v:
Gaceta Mexicana de Oncología, Vol 20, Iss 4 (2021)
Background: First and second line standard treatment in patients with metastatic colorectal cancer (mCRC) is with chemotherapy +/- some monoclonal antibody according to the RAS biomarker report. About 30-40% of them will require a third line of thera
Externí odkaz:
https://doaj.org/article/0ef558e841114da69206797d71295c4d
Autor:
Abdel Karim Dip Borunda, Ricardo Jesus Arteaga Garcia, Javier Barragan Los Santos, Rafael Medrano Guzman, Alvaro Leal Sosa, Alfonso Pimentel
Publikováno v:
Journal of Clinical Oncology. 41:524-524
524 Background: Gallbladder and other biliary tract tumors account for 0.6 % of all cancers. There is scarce data of Ampullary cancers, but it is known as an extremely rare neoplasia accounting just for 0.2% of gastrointestinal cancers and 7% of peri
Autor:
Alberto Pimentel-Rentería, Erika Ruiz-Garcia, Marytere Herrera, Consuelo Diaz-Romero, Alejandro Silva, Germán Calderillo-Ruiz, Carlos Hernández-Hernández, Karim Dip, Isabel Enríquez-Aceves, Saúl Campos-Gómez, Tirzo Suárez-Sahui, Laura Torrecillas-Torres
Publikováno v:
Gaceta Mexicana de Oncolog�a. 20
Autor:
Abdel Karim Dip Borunda, Alberto Pimentel Renteria, Rocío Grajales Álvarez, Miguel Pluma Jiménez, Mario Pérez Martínez, Juan Alejandro Silva, Yolanda Bautista Aragón, Miguel Quintana, Gloria Martinez Martinez, Samuel Rivera Rivera
Publikováno v:
Journal of Gastrointestinal Oncology. 7:632-637
Background: Stromal tumors of the digestive tract are uncommon malignant diseases, are subclassified as leiomyosarcomas and Gastrointestinal Stromal Tumors (GIST) depending on the molecular expression of tyrosine kinase receptor KIT (CD117). GISTs re
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Miguel Angel Pluma, Samuel Rivera Rivera, Abdel Karim Dip Borunda, Gloria Martinez Martinez, Miguel Quintana, Alberto Pimentel, Juan Alejandro Silva, Luis Jonathan Bueno Rosario
Publikováno v:
Journal of Clinical Oncology. 36:514-514
514 Background: Gastroenteropancreatic neuroendocrine tumors (GEP NET´s) are infrequent tumors, with a variety of symptoms depending of the kind of peptide they secrete as well as the affected organs. Long acting somatostatin analogues have shown an
Publikováno v:
Journal of Clinical Oncology. 33:224-224
224 Background: Stromal tumors of the digestive tract are uncommon malignant diseases, and are subclassified as leiomyosarcomas and gastrointestinal stromal tumors (GIST) depending on the molecular expression of CD117 (KIT). GISTs represent 1% of mal